RTO

RTO for Pharmaceutical and Chemical Industries

Print This Property
Slide

Product details reviews

    Why is RTO Essential for Pharmaceutical & Chemical Industries?

    In pharmaceutical API production, fine chemicals, intermediates, and bulk drug manufacturing, the exhaust gas typically has the following characteristics:

    Wide variety of solvents: methanol, ethanol, acetone, ethyl acetate, DMF, dichloromethane, toluene, amines, mercaptans

    Highly fluctuating concentrations, intermittent emissions, and strong odors

    Presence of chlorine, sulfur, and nitrogen, which can generate corrosive acidic gases at high temperatures

    Difficult-to-degrade VOCs, and catalytic oxidation (RCO) is prone to catalyst poisoning and deactivation

    Strict environmental regulations: VOC removal efficiency ≥99%, with stringent control on odor and halogenated compounds

    RTO (Regenerative Thermal Oxidizer) is the mainstream high-temperature destruction and heat recovery solution for VOCs and odorous gases in pharmaceutical processes such as API synthesis, solvent extraction, fermentation, and purification. It is suitable for complex multi-component solvent exhaust gases, including methanol, acetone, DMF, and dichloromethane.

    Pharmaceutical exhaust gases are highly complex, with varying physicochemical properties. They often contain halogenated and corrosive components, requiring high anti-corrosion standards. In addition, emissions are non-continuous with large concentration fluctuations, which must be carefully considered in RTO system design.

    At 760–900°C, VOCs are completely oxidized and decomposed. The ceramic honeycomb regenerator stores and releases heat bidirectionally, achieving a heat recovery efficiency ≥95%, significantly reducing fuel consumption.


    Core Working Principle of RTO for Pharmaceutical and Chemical Industries


    Preheating of exhaust gas: Ambient exhaust gas passes through the high-temperature ceramic bed and is rapidly heated to above 750°C

    High-temperature oxidation: The combustion chamber is maintained at 800–850°C, where VOCs are oxidized into CO₂ and H₂O, with a residence time ≥1.5 seconds

    Heat recovery: Clean high-temperature gas flows through another regenerator, transferring heat to the ceramic media before being discharged at lower temperature

    Valve switching: Pneumatic switching valves operate every 90–120 seconds. Three-chamber RTO systems include a purge function to prevent gas bypass, ensuring continuous closed-loop operation



    Key Components of RTO for Pharmaceutical and Chemical Industries


    (1) Burner

    Burner.jpg

    The burner is the “heart” of the RTO system, determining operational stability.


    1.Split-type design

    2.Fully automatic load modulation

    3.Multi-valve group control for safety and stability



    (2) Regenerative Ceramic Media

    Regenerative Ceramic Media.jpg


    Unique structure: parallel channel design enhances lateral airflow

    Excellent thermal shock resistance: ΔT > 400°C

    Strong anti-clogging performance, longer service life

    Lower pressure drop, reducing operating costs



    (3) Pneumatic Switching Valve

    Pneumatic Switching Valve.jpg

    1.External installation for easy maintenance

    2.Hard sealing + shaft gas sealing, leakage rate<0.1%

    3.Vertical stroke design to prevent sticking during long-term operation



    (4) Fan

    Fan.jpg


    1.High efficiency, low noise, low vibration, energy-saving

    2.Explosion-proof centrifugal design

    3.Reliable, high-quality brand suppliers



    Technical Parameters RTO for Pharmaceutical and Chemical Industries 


    Airflow capacity: 20,000 m³/h

    Exhaust sources: pharmaceutical intermediate workshops, wastewater treatment stations, tank farms

    Inlet concentration: NMHC 1500–8000 mg/m³

    Main components: toluene, acetone, ethyl acetate, dichloromethane, HCl

    Outlet emission:

    NMHC ≤ 40 mg/m³

    Benzene series ≤ 20 mg/m³

    Dichloromethane ≤ 20 mg/m³

    Chlorinated compounds < 5 mg/m³

    Removal efficiency ≥ 99%



    Core Advantages of RTO in Pharmaceutical Industry


    Ultra-high destruction efficiency: DRE ≥ 99.9%, effectively decomposing refractory odorous and heterocyclic organics

    Superior energy efficiency: Heat recovery 95%–97%, enabling self-sustaining combustion for medium-to-high concentration gases, saving 40%–60% energy compared to TO

    Strong adaptability: Handles intermittent emissions, complex compositions, and large concentration fluctuations

    High compliance: Meets ultra-low VOC emission standards with no secondary VOC leakage

    Long service life: Equipped with anti-corrosion lining for handling chlorinated, sulfur-containing, and nitrogen-containing gases


    Typical Applications in Pharmaceutical Exhaust Treatment


    API synthesis and solvent distillation recovery exhaust

    Fermentation workshop odors and alcohol/ketone VOCs

    Exhaust from crystallization, drying, and extraction processes

    Mixed odorous gases containing DMF, dichloromethane, ethyl acetate, amines, and mercaptans